Zacks Investment Research
03 Jun 2026, 17:46 UTC · 2h ago
Here's Why Investors Should Stay Neutral on MetLife Stock for Now
Search tags
Zacks Investment Research
03 Jun 2026, 17:46 UTC · 2h ago
Search tags
Story key points
3 claims · impact-rated
The Zacks Consensus Estimate for MetLife's 2026 earnings is projected to rise 12.8% year-over-year to $9.96 per share. — Strong double-digit earnings growth projections typically drive positive sentiment and price appreciation for a stock.
+0.40MetLife's forward P/E ratio of 7.97X is currently lower than the industry average of 8.77X. — A lower-than-average P/E suggests the stock may be undervalued relative to its peers, attracting value investors.
+0.30MetLife reported a 2.7% year-over-year increase in total revenues and a 3.4% increase in total premiums for the first quarter of 2026. — Positive revenue and premium growth confirm operational momentum, though the growth rate is modest.
+0.20Ticker attribution
Model heads
Continue reading
6 related stories
The article highlights strong growth prospects, positive earnings revisions, and outperformance relative to its industry.
No ticker relationship head found.
Early access
News Impact Screener scores every headline against the stocks it moves — before the chart reacts. Join the early-access list and get alerted the moment a story hits your tickers.
Impact vectors
3 dimensions · 9 clusters
Market reaction
10 bid · 0 offered
No stock impact ranking available yet.